Axsome Therapeutics
AXSM
#2993
Rank
$3.90 B
Marketcap
$78.20
Share price
-5.12%
Change (1 day)
17.91%
Change (1 year)

P/E ratio for Axsome Therapeutics (AXSM)

P/E ratio as of March 2024 (TTM): -18.3

According to Axsome Therapeutics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -18.271. At the end of 2022 the company had a P/E ratio of -16.9.

P/E ratio history for Axsome Therapeutics from 2015 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-16.955.02%
2021-10.9-63.12%
2020-29.5-42.88%
2019-51.71989.19%
2018-2.47-43.02%
2017-4.34-8.03%
2016-4.72-63.65%
2015-13.0

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-6.86-62.44%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.